Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2341 | $11.84 - $11.84 | $27,717 |
| 2024-10-21 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
A | Common Shares | A | 1231 | $0.00 - $0.00 | $0 |
| 2024-10-21 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
A | Common Shares | A | 1613 | $0.00 - $0.00 | $0 |
| 2024-10-21 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
A | Common Shares | A | 2303 | $0.00 - $0.00 | $0 |
| 2024-10-21 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
S | Common Shares | D | 100000 | $11.65 - $11.65 | $1,165,000 |
| 2024-10-21 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
M | Common Shares | A | 100000 | $3.85 - $3.85 | $385,000 |
| 2024-10-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 10945 | $11.92 - $11.92 | $130,464 |
| 2024-10-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 956 | $11.92 - $11.92 | $11,395 |
| 2024-10-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $11.92 - $11.92 | $130,464 |
| 2024-09-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2340 | $11.48 - $11.48 | $26,863 |
| 2024-09-25 | Roivant Sciences Ltd. | QVT Financial LP
() |
S | Common Shares | D | 926000 | $11.77 - $11.82 | $10,942,820 |
| 2024-09-24 | Roivant Sciences Ltd. | MANCHESTER KEITH S
(Director) |
S | Common Shares | D | 503000 | $11.62 - $11.77 | $5,866,307 |
| 2024-09-24 | Roivant Sciences Ltd. | Gold Daniel Allen
(Director) |
S | Common Shares | D | 4426000 | $11.62 - $11.82 | $51,820,726 |
| 2024-09-23 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
S | Common Shares | D | 1983257 | $11.79 - $11.79 | $23,382,600 |
| 2024-09-23 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
M | Common Shares | A | 1550000 | $3.85 - $3.85 | $5,967,500 |
| 2024-09-23 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
J | Common Shares | D | 498539 | $11.97 - $11.97 | $5,967,511 |
| 2024-09-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $11.97 - $11.97 | $131,011 |
| 2024-09-23 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
S | Common Shares | D | 250000 | $11.89 - $11.89 | $2,972,500 |
| 2024-09-23 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
M | Common Shares | A | 250000 | $3.85 - $3.85 | $962,500 |
| 2024-09-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 3087 | $11.97 - $11.97 | $36,951 |
| 2024-09-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 10945 | $11.97 - $11.97 | $131,011 |
| 2024-09-12 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
J | Common Shares | D | 3487 | $12.12 - $12.12 | $42,262 |
| 2024-09-12 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
J | Common Shares | D | 3056 | $12.12 - $12.12 | $37,038 |
| 2024-09-12 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
J | Common Shares | D | 4245 | $12.12 - $12.12 | $51,449 |
| 2024-09-12 | Roivant Sciences Ltd. | Fitzgerald Meghan
(Director) |
J | Common Shares | D | 894 | $12.12 - $12.12 | $10,835 |
| 2024-09-10 | Roivant Sciences Ltd. | MANCHESTER KEITH S
(Director) |
A | Common Shares | A | 16406 | $0.00 - $0.00 | $0 |
| 2024-09-10 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
A | Common Shares | A | 16406 | $0.00 - $0.00 | $0 |
| 2024-09-10 | Roivant Sciences Ltd. | Fitzgerald Meghan
(Director) |
A | Common Shares | A | 16406 | $0.00 - $0.00 | $0 |
| 2024-09-10 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
A | Common Shares | A | 16406 | $0.00 - $0.00 | $0 |
| 2024-08-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2341 | $12.00 - $12.00 | $28,092 |
| 2024-08-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 958 | $11.48 - $11.48 | $10,997 |
| 2024-08-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 10947 | $11.48 - $11.48 | $125,671 |
| 2024-08-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10947 | $11.48 - $11.48 | $125,671 |
| 2024-07-26 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
A | Common Shares | A | 17204821 | $0.00 - $0.00 | $0 |
| 2024-07-26 | Roivant Sciences Ltd. | Sukhatme Mayukh
(Pres&Chief Investment Officer) |
A | Common Shares | A | 18836547 | $0.00 - $0.00 | $0 |
| 2024-07-26 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
A | Common Shares | A | 204000 | $0.00 - $0.00 | $0 |
| 2024-07-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2341 | $10.80 - $10.80 | $25,282 |
| 2024-07-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $11.00 - $11.00 | $120,395 |
| 2024-07-23 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
F | Common Shares | D | 215 | $11.01 - $11.01 | $2,367 |
| 2024-07-23 | Roivant Sciences Ltd. | Oren Ilan
(Director) |
A | Common Shares | A | 2440 | $0.00 - $0.00 | $0 |
| 2024-07-23 | Roivant Sciences Ltd. | MOMTAZEE JAMES C
(Director) |
A | Common Shares | A | 1555 | $0.00 - $0.00 | $0 |
| 2024-07-23 | Roivant Sciences Ltd. | Epperly Melissa B,
(Director) |
A | Common Shares | A | 1702 | $0.00 - $0.00 | $0 |
| 2024-06-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2340 | $10.57 - $10.57 | $24,733 |
| 2024-06-20 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2129 | $10.80 - $10.80 | $22,993 |
| 2024-06-20 | Roivant Sciences Ltd. | Kumar Rakhi
(Chief Accounting Officer) |
F | Common Shares | D | 3087 | $10.80 - $10.80 | $33,339 |
| 2024-06-20 | Roivant Sciences Ltd. | Venker Eric
(President & COO) |
F | Common Shares | D | 10945 | $10.80 - $10.80 | $118,206 |
| 2024-06-20 | Roivant Sciences Ltd. | Gline Matthew
(CEO) |
F | Common Shares | D | 10945 | $10.80 - $10.80 | $118,206 |
| 2024-05-28 | Roivant Sciences Ltd. | Pulik Richard
(CFO) |
F | Common Shares | D | 2341 | $10.83 - $10.83 | $25,353 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |